The global burden of ILD and pulmonary sarcoidosis increased by 169% from 1990 to 2021, with high-SDI countries most affected. ILDs, including idiopathic pulmonary fibrosis, have a poor prognosis ...
Some results have been hidden because they may be inaccessible to you